Liz Hicken

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when Tango Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TNGX alerts

About Liz Hicken

Liz Hicken is recorded as Head of Investor Relations at Tango Therapeutics, Inc. (TNGX). Liz Hicken has spoken on 1 investor event across 1 company, most recently for Tango Therapeutics, Inc. on October 23, 2026. Tango Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tango Therapeutics, Inc. includes Malte Peters (CEO and Board Member), Malte Peters, M.D. (CEO), Barbara Weber (Chairman) and 7 others.

Liz Hicken on recent calls

“This morning, we issued a press release describing the data we will present at ESMO, which can be found on the Investors and Media section of our website, www.tangotx.com. Before we begin, let me review our Safe Harbor Statement.”

Head of Investor Relations, Tango Therapeutics Conference Call · October 23, 2026

Affiliation history

Tango Therapeutics, Inc. (TNGX)
Head of Investor Relations

Transcript header (unverified)

Current

Company network

Tango Therapeutics, Inc.

TNGX

Current role

Biotechnology · Healthcare

Head of Investor Relations

1 appearance Latest appearance 2026-10-23

View calls and events

Leadership on record at Tango Therapeutics, Inc.

Malte Peters CEO, Board Member
Malte Peters, M.D. CEO
Barbara Weber Chairman
Barbara Weber, M.D. Chairman
Matthew Gall CFO
Douglas Barry General Counsel
Jessica Newcomb Chief Accounting Officer
James B. Avery Board Member
John Ketchum Board Member
Lesley Ann Calhoun Board Member

Recent activity

Conference Tango Therapeutics Conference Call Tango Therapeutics, Inc. (TNGX)
2026-10-23